We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Editorial |

Vitamin E and the Age-Related Eye Disease Study Supplementation for Age-Related Macular Degeneration

Emily Y. Chew, MD; Traci Clemons, PhD
Arch Ophthalmol. 2005;123(3):395-396. doi:10.1001/archopht.123.3.395.
Text Size: A A A
Published online


An oral presentation at the November 2004 meeting of the American College of Physicians in New Orleans, La, which summarized a meta-analysis of controlled clinical trials of vitamin E, received much attention from the press, with headlines such as “Vitamin E Supplements Might Kill You” and “Vitamin E Can Be Deadly.” The article,1 published in the January 2005 edition of the Annals of Internal Medicine, reports that taking high-dose vitamin E supplements does not lower the risk of death and might be associated with a small increase in the risk of death. These study conclusions have resulted in confusion among the treating physicians and persons who are at moderate or high risk for developing age-related macular degeneration (AMD) and who are taking the Age-Related Eye Disease Study (AREDS) supplements that include 400 international units (IU) of vitamin E daily.2

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Antioxidants and vision health: facts and fiction. Mol Cell Biochem 2014;388(1-2):173-83.

Users' Guides to the Medical Literature
Table 9.2-3 Refuted Evidence From Observational Studiesa